이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!
Shandong Weigao Group Medical Polymer 과거 수익 실적
과거 기준 확인 2/6
Shandong Weigao Group Medical Polymer은 연평균 8.5%의 비율로 수입이 증가해 온 반면, Medical Equipment 산업은 수입이 증가했으며, 연간 10.9%였습니다. 매출은 연평균 8.6%의 비율로 증가했습니다. Shandong Weigao Group Medical Polymer의 자기자본이익률은 8.6%이고 순이익률은 15.1%입니다.
주요 정보
8.5%
수익 성장률
8.3%
EPS 성장률
| Medical Equipment 산업 성장 | 13.7% |
| 매출 성장률 | 8.6% |
| 자기자본 수익률 | 8.6% |
| 순이익 | 15.1% |
| 최근 수익 업데이트 | 31 Dec 2023 |
최근 과거 실적 업데이트
Recent updates
Shandong Weigao Group Medical Polymer Company Limited's (HKG:1066) 27% Share Price Plunge Could Signal Some Risk
Jun 25
Here's What To Make Of Shandong Weigao Group Medical Polymer's (HKG:1066) Decelerating Rates Of Return
Jun 23Shandong Weigao Group Medical Polymer's (HKG:1066) Shareholders Will Receive A Bigger Dividend Than Last Year
May 31We Think Shandong Weigao Group Medical Polymer Company Limited's (HKG:1066) CEO Compensation Package Needs To Be Put Under A Microscope
May 22Earnings Not Telling The Story For Shandong Weigao Group Medical Polymer Company Limited (HKG:1066)
Apr 23Analysts Have Lowered Expectations For Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) After Its Latest Results
Mar 28Shandong Weigao Group Medical Polymer Company Limited's (HKG:1066) Shares May Have Run Too Fast Too Soon
Jan 09Returns On Capital Are Showing Encouraging Signs At Shandong Weigao Group Medical Polymer (HKG:1066)
Dec 22Are Investors Undervaluing Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) By 44%?
Nov 10Does Shandong Weigao Group Medical Polymer (HKG:1066) Have A Healthy Balance Sheet?
Oct 05Return Trends At Shandong Weigao Group Medical Polymer (HKG:1066) Aren't Appealing
Aug 01Is Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Trading At A 28% Discount?
Jul 19Shandong Weigao Group Medical Polymer (HKG:1066) Ticks All The Boxes When It Comes To Earnings Growth
Jun 22Is Shandong Weigao Group Medical Polymer (HKG:1066) Using Too Much Debt?
Jun 09The Returns At Shandong Weigao Group Medical Polymer (HKG:1066) Aren't Growing
Apr 27Shandong Weigao Group Medical Polymer (HKG:1066) Ticks All The Boxes When It Comes To Earnings Growth
Mar 17A Look At The Intrinsic Value Of Shandong Weigao Group Medical Polymer Company Limited (HKG:1066)
Feb 27Returns On Capital At Shandong Weigao Group Medical Polymer (HKG:1066) Have Hit The Brakes
Jan 18Does Shandong Weigao Group Medical Polymer (HKG:1066) Have A Healthy Balance Sheet?
Dec 12Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Shares Could Be 21% Below Their Intrinsic Value Estimate
Nov 29Here's Why We Think Shandong Weigao Group Medical Polymer (HKG:1066) Might Deserve Your Attention Today
Nov 14Shandong Weigao Group Medical Polymer (HKG:1066) Is Paying Out A Larger Dividend Than Last Year
Oct 03The Returns At Shandong Weigao Group Medical Polymer (HKG:1066) Aren't Growing
Sep 21Shandong Weigao Group Medical Polymer (HKG:1066) Could Easily Take On More Debt
Sep 05Shandong Weigao Group Medical Polymer Company Limited's (HKG:1066) Intrinsic Value Is Potentially 27% Above Its Share Price
Aug 23Here's Why Shandong Weigao Group Medical Polymer (HKG:1066) Has Caught The Eye Of Investors
Aug 08There's Been No Shortage Of Growth Recently For Shandong Weigao Group Medical Polymer's (HKG:1066) Returns On Capital
Jun 22Shandong Weigao Group Medical Polymer (HKG:1066) Will Pay A Smaller Dividend Than Last Year
Jun 08An Intrinsic Calculation For Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Suggests It's 27% Undervalued
May 16Is Shandong Weigao Group Medical Polymer (HKG:1066) A Risky Investment?
May 03Shandong Weigao Group Medical Polymer's (HKG:1066) Returns On Capital Are Heading Higher
Mar 17Is There An Opportunity With Shandong Weigao Group Medical Polymer Company Limited's (HKG:1066) 42% Undervaluation?
Jan 28Does Shandong Weigao Group Medical Polymer (HKG:1066) Deserve A Spot On Your Watchlist?
Jan 13Returns Are Gaining Momentum At Shandong Weigao Group Medical Polymer (HKG:1066)
Dec 17Shandong Weigao Group Medical Polymer (HKG:1066) Seems To Use Debt Rather Sparingly
Dec 05An Intrinsic Calculation For Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Suggests It's 32% Undervalued
Oct 18Do Shandong Weigao Group Medical Polymer's (HKG:1066) Earnings Warrant Your Attention?
Oct 06Shandong Weigao Group Medical Polymer (HKG:1066) Shareholders Will Want The ROCE Trajectory To Continue
Sep 10Shandong Weigao Group Medical Polymer (HKG:1066) Has A Rock Solid Balance Sheet
Aug 29Calculating The Fair Value Of Shandong Weigao Group Medical Polymer Company Limited (HKG:1066)
Jul 09Here's Why I Think Shandong Weigao Group Medical Polymer (HKG:1066) Might Deserve Your Attention Today
Jun 26Investors Met With Slowing Returns on Capital At Shandong Weigao Group Medical Polymer (HKG:1066)
Jun 02These 4 Measures Indicate That Shandong Weigao Group Medical Polymer (HKG:1066) Is Using Debt Reasonably Well
Apr 24수익 및 비용 분석
수익 및 비용 분석
Shandong Weigao Group Medical Polymer 수익 창출 및 지출 방식. 최근 보고된 수익 기준, LTM 기준.
수익 및 매출 내역
| 날짜 | 수익 | 수익 | G+A 비용 | R&D 비용 |
|---|---|---|---|---|
| 31 Dec 23 | 13,229 | 2,002 | 3,837 | 593 |
| 30 Sep 23 | 13,398 | 2,221 | 3,793 | 597 |
| 30 Jun 23 | 13,438 | 2,399 | 3,631 | 592 |
| 31 Mar 23 | 13,529 | 2,561 | 3,604 | 569 |
| 31 Dec 22 | 13,747 | 2,764 | 3,694 | 556 |
| 30 Sep 22 | 13,903 | 2,676 | 3,725 | 551 |
| 30 Jun 22 | 14,058 | 2,589 | 3,755 | 546 |
| 31 Mar 22 | 13,633 | 2,432 | 3,793 | 525 |
| 31 Dec 21 | 13,209 | 2,276 | 3,830 | 503 |
| 30 Sep 21 | 12,923 | 2,288 | 3,865 | 493 |
| 30 Jun 21 | 12,636 | 2,300 | 3,900 | 484 |
| 31 Mar 21 | 12,129 | 2,194 | 3,775 | 454 |
| 31 Dec 20 | 11,622 | 2,087 | 3,651 | 424 |
| 30 Sep 20 | 11,139 | 1,998 | 3,636 | 403 |
| 30 Jun 20 | 10,656 | 1,909 | 3,622 | 382 |
| 31 Mar 20 | 10,520 | 1,879 | 3,699 | 394 |
| 31 Dec 19 | 10,384 | 1,850 | 3,776 | 406 |
| 30 Sep 19 | 9,993 | 1,805 | 3,696 | 374 |
| 30 Jun 19 | 9,602 | 1,760 | 3,615 | 341 |
| 31 Mar 19 | 9,205 | 1,616 | 3,500 | 326 |
| 31 Dec 18 | 8,809 | 1,473 | 3,385 | 311 |
| 30 Jun 18 | 7,465 | 1,255 | 2,842 | 280 |
| 31 Mar 18 | 6,879 | 1,255 | 2,593 | 277 |
| 31 Dec 17 | 6,293 | 1,255 | 2,344 | 274 |
| 30 Jun 17 | 5,402 | 1,297 | 1,918 | 258 |
| 31 Mar 17 | 5,511 | 1,165 | 2,062 | 262 |
| 31 Dec 16 | 5,620 | 1,033 | 2,206 | 266 |
| 30 Sep 16 | 6,484 | 1,010 | 2,469 | 302 |
| 30 Jun 16 | 6,237 | 914 | 2,367 | 302 |
| 31 Mar 16 | 6,078 | 1,013 | 2,153 | 297 |
| 31 Dec 15 | 5,919 | 1,113 | 1,938 | 293 |
| 30 Sep 15 | 5,878 | 1,237 | 1,920 | 290 |
| 30 Jun 15 | 5,610 | 1,196 | 1,839 | 262 |
| 31 Mar 15 | 5,548 | 1,161 | 1,828 | 252 |
| 31 Dec 14 | 5,278 | 1,085 | 1,742 | 238 |
| 30 Sep 14 | 5,011 | 307 | 1,646 | 222 |
| 30 Jun 14 | 4,996 | 431 | 1,583 | 222 |
| 31 Mar 14 | 4,769 | 376 | 1,521 | 215 |
| 31 Dec 13 | 4,613 | 388 | 1,453 | 209 |
| 30 Sep 13 | 4,230 | 1,007 | 1,212 | 319 |
양질의 수익: 1066 은 높은 수익을 보유하고 있습니다.
이익 마진 증가: 1066 의 현재 순이익 이익률 (15.1%) 작년보다 낮습니다 (20.1%).
잉여현금흐름 대 수익 분석
과거 수익 성장 분석
수익추이: 1066 의 수입은 지난 5년 동안 매년 8.5% 씩 증가했습니다.
성장 가속화: 1066 은(는) 지난 1년 동안 마이너스 수익 성장을 기록했기 때문에 5년 평균과 비교할 수 없습니다.
수익 대 산업: 1066 은 지난 1년 동안 마이너스 수익 성장( -27.6% )을 기록하여 Medical Equipment 업계 평균( -8.3% ).
자기자본 수익률
높은 ROE: 1066 의 자본 수익률( 8.6% )은 낮음으로 간주됩니다.